Earnings call transcript: AbCellera beats Q3 2026 estimates as ABCL635 lifts shares

🌐 Investing.com (Cyprus) —
Earnings call transcript: AbCellera beats Q3 2026 estimates as ABCL635 lifts shares

AI Summary

AbCellera reportedly beat third-quarter 2026 earnings estimates, with its ABCL635 program cited as a factor behind a rise in shares. The supplied article provides no further financial or clinical details.

Markets Health AbCellera Q3 2026 earnings ABCL635 shares biotechnology

Read original source →